Drug Free Sltn Stock Price, News & Analysis
Company Description
Drug Free Sltn (OTC Link: DSOL) is a publicly traded health information services company in the Healthcare sector. The company has a market capitalization of $28.3M.
DSOL stock has gained 250.0% over the past year. Shares last traded at $0.0014.
This page provides a comprehensive overview of DSOL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Drug Free Sltn (DSOL) stock last traded at $0.0014. Over the past 12 months, the stock has gained 250.0%. At a market capitalization of $28.3M, DSOL is classified as a micro-cap stock with approximately 283.4M shares outstanding.
Latest News
Drug Free Sltn has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include management. View all DSOL news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
DSOL Company Profile & Sector Positioning
Drug Free Sltn (DSOL) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DSOL often look at related companies in the same sector, including Renalytix Plc (RNLXY), Revium Recovery Inc (RVRC), Reliq Helth Tech (RQHTF), Veri Medtech Holdings (VRHI), and Treatment.com AI (TREIF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DSOL's relative position within its industry.